ABHD5 and colorectal carcinoma: TAMs exhibit a heterogeneous expression of the hydrolase domain containing the triglyceride hydrolytic activator 5 (ABHD5) which is expressed in low-level in migratory TAMs and upregulate matrix metalloproteinases (MMPs) involved in CRC metastasis (119).